tradingkey.logo
tradingkey.logo
Buscar

Gelteq Ltd

GELS
Añadir a la lista de seguimiento
0.580USD
-0.080-12.17%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
6.21MCap. mercado
PérdidaP/E TTM

Más Datos de Gelteq Ltd Compañía

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Información de Gelteq Ltd

Símbolo de cotizaciónGELS
Nombre de la empresaGelteq Ltd
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoGivoni (Nathan Jacob)
Número de empleados7
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 29
DirecciónLevel 4
CiudadMELBOURNE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísAustralia
Código postal3205
Teléfono61390873990
Sitio Webhttps://www.gelteq.com
Símbolo de cotizaciónGELS
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoGivoni (Nathan Jacob)

Ejecutivos de Gelteq Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Gelteq Ltd?

Los cinco principales accionistas de Gelteq Ltd son: Mr. Nathan Jacob Givoni

¿Cuántas instituciones poseen acciones de Gelteq Ltd (GELS)?

A fecha de 2026Q1, 9 instituciones poseen acciones de Gelteq Ltd, con un valor de mercado combinado de aproximadamente 87.15K, lo que representa el 0.81% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -29363.00.